Basic Furadantin Information

• INN (International Nonproprietary Name): Nitrofurantoin.
• Brand Names Available In Canada (English): Macrodantin, Novo-Furan (oral suspension); generics supplied by Mylan, Sandoz, Teva are available in Canada.
• ATC Code: J01XE01.
• Forms & Dosages: Capsules 25 mg, 50 mg, 100 mg, 100 mg ER; tablets 100 mg (varies); oral suspension 25 mg/5 mL and 50 mg/5 mL for pediatric use.
• Manufacturers In Canada (English): Novo Nordisk supplies Novo-Furan suspension in Canada; generics are available from Mylan, Sandoz, Teva and others.
• Registration Status In Canada (English): Registered and supplied in Canada; specific product listings should be confirmed via Health Canada or provincial formularies.
• OTC / Rx Classification: Prescription only (Rx) in Canada.

Latest Research Highlights

Worried about rising UTI resistance and whether nitrofurantoin still works?

Recent surveillance studies from 2022–2025 continue to show strong activity of nitrofurantoin against uncomplicated cystitis caused by Escherichia coli.

Community susceptibility in many regional series is commonly high, often reported above 85–95% for E. coli.

International comparative trials reaffirm nitrofurantoin’s lower collateral damage compared with fluoroquinolones and trimethoprim‑sulfamethoxazole for lower urinary tract infections.

Systematic reviews favour nitrofurantoin for symptom resolution in uncomplicated cystitis but consistently note it is not suitable for upper tract infections like pyelonephritis.

Pharmacovigilance reports from 2022–2025 highlight rare but serious pulmonary and hepatic adverse events.

The frequency of these serious events is low, but risk increases with prolonged use and in older adults.

In Canada, antimicrobial stewardship programmes in hospitals and primary care emphasise nitrofurantoin as a first‑line oral option for uncomplicated cystitis to preserve broader‑spectrum agents.

Rural and Indigenous communities report challenges with access to diagnostics and follow‑up, so evidence‑backed short‑course strategies for uncomplicated cystitis are highly valued.

Clinical Effectiveness In Canada

Are Canadian guidelines aligned with international evidence on nitrofurantoin?

Health Canada product monographs and national guidance align with international evidence that nitrofurantoin is effective for uncomplicated lower urinary tract infections.

Canadian antimicrobial stewardship guidelines and most provincial formularies list nitrofurantoin as a recommended first‑line option for cystitis.

Provincial laboratory surveillance continues to show consistent community susceptibility patterns supporting its use for E. coli cystitis.

Clinicians should verify Drug Identification Number (DIN) and formulation in Health Canada’s Drug Product Database before prescribing to ensure the exact product matches provincial coverage.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list different product strengths and have varying coverage criteria.

Seniors and low‑income patients commonly rely on public coverage, which influences whether a generic or brand product is dispensed.

In Quebec and federally, bilingual labelling and pharmacist counselling are expected and should be offered when dispensing nitrofurantoin.

Indications And Expanded Uses

Can nitrofurantoin be used beyond simple bladder infections?

Regulatory approvals and product monographs specify nitrofurantoin for treatment and prophylaxis of uncomplicated cystitis only.

Nitrofurantoin is not approved for pyelonephritis, prostatitis, or systemic infections because its tissue penetration is limited.

Some Canadian clinicians use low‑dose nightly nitrofurantoin for recurrent UTI prophylaxis under careful monitoring and documentation.

Pediatric use is supported from age one month and older with weight‑based dosing per the monograph.

In remote and Indigenous communities, recurrent UTI management emphasises prevention and culturally safe care when considering long‑term prophylaxis.

Long‑term prophylaxis decisions must balance benefit versus risks such as pulmonary toxicity and peripheral neuropathy, and include renal function monitoring.

Composition And Brand Landscape

Which brands and formulations of nitrofurantoin are commonly seen in Canada?

The active ingredient is nitrofurantoin (INN) and international brands include Furadantin, Macrodantin, Macrobid and Furabid.

In Canada, Novo‑Furan is available as an oral suspension and Macrodantin and generics are reported in supply chains.

Formulations sold globally and in Canada include capsules 25 mg, 50 mg, 100 mg, extended‑release 100 mg, and oral suspensions 25–50 mg/5 mL for pediatric dosing.

Market audits from 2022–2024 show a robust generic supply from Mylan, Sandoz and Teva alongside branded suspension supplies from Novo Nordisk.

Prescribers typically choose generics for cost and formulary alignment, and pharmacists confirm DINs at dispensing.

Rural pharmacies may stock fewer formulations than urban chains, and oral suspension is sometimes less available outside major centres.

Contraindications And Special Precautions

Who should avoid nitrofurantoin or take extra precautions?

Absolute contraindications include severe renal impairment with CrCl less than 30 mL/min, known hypersensitivity to nitrofurantoin, prior nitrofurantoin‑associated jaundice or hepatic dysfunction, pregnancy at term (≥38 weeks), and infants under one month of age.

Relative cautions include G6PD deficiency, advanced age because of higher pulmonary and neuropathy risk, active liver disease and existing peripheral neuropathy risk factors.

Pharmacovigilance data note rare but serious pulmonary and hepatic events, with increased risk during prolonged therapy.

For Indigenous and elderly patients who may have higher baseline comorbidity, screening renal function and documenting risk discussion is recommended before starting therapy.

Pharmacists should counsel patients to report red‑flag symptoms immediately, such as new or worsening shortness of breath, persistent cough, unexplained fever, yellowing of the skin or eyes, or new numbness and tingling.

Dosage Guidelines

How should nitrofurantoin be dosed for adults, children and prophylaxis?

Standard adult dosing for uncomplicated cystitis is 50–100 mg every six hours for seven days.

Extended‑release 100 mg formulations are commonly dosed twice daily rather than four times daily.

Pediatric dosing for infants one month and older is 5–7 mg/kg/day divided into four doses.

Prophylaxis is typically 50–100 mg at bedtime for recurrent infections, using the lowest effective dose and regular review.

Nitrofurantoin should be avoided if estimated glomerular filtration rate or creatinine clearance is below 30 mL/min.

If a dose is missed, take it as soon as remembered unless it is almost time for the next dose; do not double up.

In case of overdose with severe nausea or vomiting, seek emergency medical care for supportive treatment as advised in the product monograph.

Interactions Overview

Will nitrofurantoin interact with other medicines I take?

Nitrofurantoin has relatively few drug–drug interactions compared with many oral antibiotics because it is rapidly excreted into urine.

Drugs that impair renal function may reduce nitrofurantoin efficacy and should be reviewed prior to starting therapy.

There is concern about additive neuropathy risk when used with agents that also cause neuropathy, such as some antivirals and chemotherapeutics.

Over‑the‑counter remedies and supplements, including multivitamins and common herbal products, rarely alter nitrofurantoin levels but should be disclosed to the prescriber and pharmacist.

For patients using traditional medicines in Indigenous communities, an open discussion about concurrent use helps identify any potential interactions and maintain safety.

Cultural Perceptions And Patient Habits

What do Canadian patients say about nitrofurantoin online and at the pharmacy counter?

Patient forums and pharmacy feedback from 2022–2024 show many people value nitrofurantoin for quick symptom relief and its lower potential to drive resistance compared with broader agents.

Common concerns include gastrointestinal side effects, brown urine discolouration and occasional difficulty finding specific formulations like suspension in smaller centres.

Urban patients report easy access and helpful pharmacist counselling, while rural users note stock limitations, delayed fills and reliance on telehealth consultations.

Canadian expectations around universal healthcare lead patients to ask about coverage, out‑of‑pocket cost and generic substitution.

Provision of bilingual resources in English and French and Indigenous‑friendly materials improves understanding and adherence across diverse communities.

Patients can ask major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs about generic equivalents to reduce cost and align with provincial formularies.

Availability And Pricing Patterns

Where can Canadians get nitrofurantoin and what affects the price?

Nitrofurantoin is prescription‑only across Canada, and common suppliers include Novo‑Furan suspension and generics from Teva, Sandoz and Mylan.

Packaging is typically 30, 50 or 100 capsules or a 100 mL suspension bottle for pediatric use.

Provincial formularies and private drug plans determine which brands are dispensed and whether prior authorizations are required for prophylaxis.

Major pharmacy chains generally stock generics, while rural pharmacies sometimes rely on inter‑pharmacy transfers or mail order to obtain specific strengths.

Online Canadian pharmacies require a valid prescription for nitrofurantoin, and patients should verify coverage before ordering.

In our online pharmacy, furadantin is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Cross‑border US pricing can be lower for some branded formulations like Macrobid or Furadantin, but importation rules and prescription validation vary and may affect timely access.

Comparable Medicines And Preferences

What are suitable alternatives to nitrofurantoin for uncomplicated cystitis in Canada?

Alternatives include fosfomycin, trimethoprim, sulfamethoxazole‑trimethoprim and, in selected cases, oral beta‑lactams.

Fluoroquinolones such as ciprofloxacin are reserved because of higher risk of adverse events and greater impact on resistance selection pressures.

Comparative studies emphasise nitrofurantoin’s advantage in preserving gut flora and having lower selection pressure for resistance when used for lower UTIs.

Choice of agent is regionally guided by local resistance patterns and individual patient factors such as pregnancy, renal function and allergies.

When counselling patients, weigh efficacy, side‑effect profile, pregnancy safety, cost and dosing convenience in a pros and cons checklist.

Patients who travel to the United States may encounter different brand availability, such as Macrobid being more common in the US, which can affect adherence if dosing differs.

Frequently Asked Questions

• Q: Is nitrofurantoin available over the counter in Canada?
• A: No; nitrofurantoin is prescription only in Canada, and pharmacists will ask for a valid prescription and check provincial dispensing policies and DIN listings.
• Q: Can I take nitrofurantoin if I have reduced kidney function?
• A: Avoid nitrofurantoin if estimated eGFR or creatinine clearance is below 30 mL/min; prescribers should check renal function before starting therapy.
• Q: Why does my urine look brown while on nitrofurantoin?
• A: Brown or dark urine is a benign effect of nitrofurantoin; report severe gastrointestinal or respiratory symptoms to your pharmacist or doctor.
• Q: Is nitrofurantoin safe in pregnancy?
• A: Nitrofurantoin is avoided at term from 38 weeks due to neonatal hemolysis risk and is contraindicated in neonates under one month; discuss alternatives and timing with your prescriber.

Guidelines For Proper Use

What should pharmacists and prescribers check before and during nitrofurantoin therapy?

Confirm the indication is uncomplicated cystitis and not an upper tract infection or prostatitis before dispensing nitrofurantoin.

Review recent renal function results and check for absolute contraindications such as pregnancy at term, prior nitrofurantoin‑related jaundice, or severe renal impairment.

Ask about G6PD status, existing neuropathy, liver disease and concurrent medications that impair renal function or increase neuropathy risk.

Use teach‑back to confirm dosing instructions, offer bilingual written take‑home information, and document counselling according to provincial regulations.

For rural and remote patients, suggest mail‑order options and provincial drug mail programs where available to ensure continuity of therapy and access to the correct formulation.

Emphasise antimicrobial stewardship: use the shortest effective course and review any continued prophylaxis regularly for safety and ongoing need.

Delivery Across Canada (English)